Human erythrocyte-derived nanovesicles can readily be loaded with doxorubicin and act as anticancer agents.
Cancer Research Frontiers(2018)
摘要
Purpose: In future therapeutics new formulas are needed that assure lower doses, fewer side effects, targeted administration and protection of the drug from degradation. In a first step to fulfil t ...
更多查看译文
关键词
nanovesicles,doxorubicin,anticancer agents,erythrocyte-derived
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要